Lex lata cannabis legalization: statement at the 2022 United Nations Commission on Narcotic Drugs

[Video] Plenary statement at the 65th UN Commission on Narcotic Drugs, about a cannabis legalization compliant with the drug conventions

History, science, and politics of international cannabis scheduling, 2015–2021

Just published: Oct. 2021 report on the 2015-2021 cannabis scheduling process at the WHO and United Nations (open access PDF)

Press release — History made today: UN recognizes medical cannabis

After 60 years of status quo, 3 years of scientific review by WHO and 2 years of diplomatic discussions, today, the United Nations finally withdrew cannabis from 1961 Convention Schedule IV –the “prohibition schedule”

WHO cannabis vote: Support patient access to medicine, vote yes! [signed by 193 NGOs]

194 organizations from 50 countries call for Cannabis deschedulling at the United Nations in official statement.

Breaking news: WHO changes position on medical Cannabis after 60 years.

PRESS RELEASE | 31st Jan. 2019 | Outcome of #ECDD41 on Cannabis. World Health Organization acknowledges medical use of Cannabis after 60 years of denial.

ECDD41: WHO finishes this week its historic review of Cannabis

WHO finishes this week their scientific review of cannabis, THC, CBD extracts, etc. Their conclusions could change cannabis scheduling in the drug Treaties.

International Cannabis Policy Conference | Vienna 2018

FAAAT launches the International Cannabis Policy Conference | Vienna, Austria | December 7-9, 2018 | #CannabiSDG | www.cannabis-conference.com

Cannabis: WHO just acknowledged historical misjudgment and heads towards global policy update

After thoroughly assessing Cannabis, THC and CBD in June, the WHO has just recognized its historical misjudgment that led to the placement of Cannabis medicines among heroin or fentanyl derivates, and will consider an international change of scheduling to adequate policies with evidence. #ECDD40

ECDD40 in Geneva: pivotal moment for global Cannabis policies

This week in Geneva for the first time ever, the WHO drugs committee has heard the voices of doctors, patients, and researchers, and started to weigh the harms and benefits of Cannabis neutrally.

Cannabis review by the WHO: all you need to know

In 2018 for the first time, the World Health Organization is assessing the medical uses and harms of Cannabis, and will recommend the suitable classification to be applied internationally. We promote an objective and independent assessment, that recognizes and acknowledges modern research on Cannabis. Support us!

Crimson paper #2. The committee.

The crimson papers are a series of short documents aimed at sharing knowledge regarding the process of scheduling plants, medicines and substances within the international drug control treaty framework.

Crimson paper #1. The schedules.

The crimson papers are a series of short documents aimed at sharing knowledge regarding the process of scheduling plants, medicines and substances within the international drug control treaty framework.

Reassessing substances: a proposed reading of the UNGASS 2016 outcome document

FAAAT submitted a contribution to the post-UNGASS 2016 thematic debates organized by the UN Commission on Narcotic Drugs, on October 2016. This contribution has been posted online on the website of the UNODC and can be downloaded here.

Actions à la 69ème Assemblée Mondiale de la Santé

Résumé des actions du do-tank FAAAT à la 69ème Assemblée Mondiale de la Santé à Genève, du 23 au 28 mai 2016.